AKT1 and chronic myelogenous leukemia, BCR-ABL1 positive: Additionally, abnormally activated CXCR2 expression induces dipeptidyl peptidase IV (DPP4/CD26), a marker of CML leukemia stem cells, and inhibits the PI3K/Akt/mTOR pathway cascade.